...
首页> 外文期刊>ChemMedChem >Focused Libraries of 16-Substituted Estrone Derivatives and Modified E-Ring Steroids:Inhibitors of 17beta-Hydroxysteroid Dehydrogenase Type 1
【24h】

Focused Libraries of 16-Substituted Estrone Derivatives and Modified E-Ring Steroids:Inhibitors of 17beta-Hydroxysteroid Dehydrogenase Type 1

机译:重点图书馆的16取代的雌酮衍生物和修饰的E环类固醇:17beta羟基类固醇脱氢酶1型的抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

17beta-Hydroxysteroid dehydrogenase type 1 (17beta-HSD1),an oxido-reductase which has a preferential reductive activity using NADPH as cofactor,converts estrone to estradiol and is expressed in many steroidogenic tissues including breast and in malignant breast cells.As estradiol stimulates the growth and development of hormone-dependent breast cancer,inhibition of the final step of its synthesis is an attractive target for the treatment of this disease.The parallel synthesis of novel focused libraries of J6-substituted estrone derivatives and modified E-ring pyrazole steroids as new potent 17beta-HSD1 inhibitors is described.Substituted 3-O-sulfamoylated estrone derivatives were used as templates and were immobilised on 2-chlorotrityl chloride resin to give resin-bound scaffolds with a multi-detachable linker.Novel focused libraries of 16-substituted estrone derivatives and new modified E-ring steroids were assembled from these immobilised templates using solid-phase organic synthesis and solution-phase methodologies.Among the derivatives synthesised,the most potent 17beta-HSD1 inhibitors were 25 and 26 with IC_(50) values in T-47D human breast cancer cells of 27 and 165 nm,respectively.Parallel synthesis resulting in a library of C5'-linked amides from the pyrazole E-ring led to the identification of 62 with an IC_(50) value of 700 nm.These potent inhibitors of 17beta-HSD1 have a 2-ethyl substituent which will decrease their estrogenic potential.Several novel 17beta-HSD1 inhibitors emerged from these libraries and these provide direction for further template exploration in this area.A new efficient diastereoselective synthesis of 25 has also been developed to facilitate supply for in vivo evaluation,and an X-ray crystal structure of this inhibitor is presented.
机译:17beta-羟基类固醇脱氢酶1(17beta-HSD1)是一种氧化还原酶,使用NADPH作为辅因子具有优先的还原活性,可将雌酮转化为雌二醇,并在包括乳房在内的许多类固醇生成组织中以及在恶性乳腺细胞中表达。激素依赖性乳腺癌的生长和发展,抑制其合成的最终步骤是治疗该疾病的诱人目标。J6取代的雌酮衍生物和修饰的E环吡唑类固醇的新型聚焦库的并行合成描述了新型有效的17beta-HSD1抑制剂,以取代的3-O-氨磺酰化的雌酮衍生物为模板,固定在2-氯三苯甲基氯树脂上,制得具有多可分离接头的树脂结合支架。使用固相有机合成法从这些固定的模板组装了雌酮衍生物和新的修饰的E环类固醇在合成的衍生物中,最有效的17beta-HSD1抑制剂分别在27和165 nm的T-47D人乳腺癌细胞中分别具有25和26的IC_(50)值。并行合成生成一个库从吡唑E环中分离出C5'连接的酰胺导致鉴定出62,IC_(50)值为700 nm。这些有效的17beta-HSD1抑制剂具有2-乙基取代基,这将降低其雌激素作用。这些文库中出现了新型的17beta-HSD1抑制剂,它们为该领域的进一步模板探索提供了方向。还开发了一种新的有效的非对映选择性合成25,以促进体内评估的供应,以及该抑制剂的X射线晶体结构被表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号